FDA Approved: LENALIDOMIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for lenalidomide (ANDA211022), authorizing the marketing of a generic lenalidomide product with the same in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome with 5q Deletion

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

SUPPL AP for LENALIDOMIDE (LENALIDOMIDE)